---加拿大生物技术公司Microbix Biosystems（MBX.TO: 行情）周二表示，将与湖南生物医药集团联手建设亚洲规模zui大的流感疫苗生产基地。 Microbix称，已与湖南生物医药集团成立合作企业，共同建设和运营位于长沙市附近两亿美元的疫苗生产基地。 这将是世界第三大疫苗生产基地。2013年全面投产後，该基地每年将能够生产超过1亿剂的季节流感疫苗，以及高达3亿剂的一种可预防流感大流行病毒的疫苗，包括甲流病毒。预计工程将于2010年初启动。 Microbix董事长兼*执行官William Gastle向路透表示：“我们将解决中国一个尚未被满足的医疗需求，一些国家疫苗产能不足，无法满足国内人口的疫苗需求，中国就是其中之一。” | EL-15-02 | | 1 ml | | EL-01-02 | Cytomegalovirus, Grade 2 | 1 ml | | EL-22-02 | Dengue Type 2 | 1 ml | | EL-16-03 | Epstein Barr Virus, Cell Extract | 1 ml | | EL-16-06 | EBV Viral Capsid Ag, Purified | 1 ml | | EL-25-01 | Hepatitis A, Grade 2 | 1 ml | | EL-02-02 | Herpes Simplex 1, Grade 2 | 1 ml | | EL-23-02 | Herpes Simplex 2, Grade 2 | 1 ml | | EL-13-02 | Influenza A, Grade 2 | 1 ml | | EL-13-AD | Influenza A Nucleoprotein *NEW* | 20 ug | | EL-14-03 | Influenza B, Grade 2 | 1 ml | | EL-04-02 | Measles, Grade 2 | 1 ml | | EL-06-02 | Mumps, Grade 2 | 1 ml | | EL-08-02 | Parainfluenza 1, Grade 2 | 1 ml | | EL-09-02 | Parainfluenza 2, Grade 2 | 1 ml | | EL-10-02 | Parainfluenza 3, Grade 2 | 1 ml | | EL-35-02 | Rotavirus | 1 ml | | EL-07-02 | Respiratory Syncytial Virus, Grade 2 | 1 ml | | EL-07-AB | Respiratory Syncytial Virus. Purified *NEW* | 1 mg | | EL-05-13 | Rubella K0S Concentrate | 1 ml | | EL-05-10 | Rubella K1S | 1 ml | | EL-05-11 | Rubella K2S | 1 mg | | EL-03-02 | Varicella-Zoster, Grade 2 | 1 ml | | EL-11-02 | Mycoplasma pneumoniae, Grade 2 | 1 ml | | EL-12-02 | Chlamydia trachomatis, Grade 2 | 1 ml | | EL-46-02 | Chlamydia pneumoniae | 1 ml | | PD-01-60 | pΔE1sp1A, pΔE1sp1B, pFG140 and pJM17 | Kit A | | PD-01-61 | pAB26, pAB27, pFG140 and pFG173 | Kit B | | PD-01-62 | pΔE1sp1A, pΔE1sp1B, pXC1, pABS.4, pFG140, pBHG10, pBHG11 | Kit C | | PD-01-64 | pDC311, pDC312, pDC315, pDC316, pBHGloxΔE1,3Cre, pFG140 | | PD-01-65 | pDC511, pDC512, pDC515, pDC516, pBHGfrtΔE1,3FLP, and pFG140 | | PD-01-67 | pDC411, pDC412, pDC415, pDC416, pBHG10, pBHGE3 and pFG140 | | PD-01-66 | AdCreM2, AdfloxLacZ1 and Adfloxluc | | PD-01-68 | pDC315（io）, pDC316（io）, pBHGloxΔE1,3Cre, pFG140, 293IQ Cells | | PD-01-69 | pDC515（io）, pDC516（io）, pBHGfrtΔE1,3FLP, pFG140, 293IQ Cells | | PD-01-01 | pΔE1sp1A | | PD-01-02 | pΔE1sp1B | | PD-01-03 | pXC1 | | PD-01-04 | PABS.4 | | PD-01-05 | pFG140 | | PD-01-06 | pJM17 | | PD-01-07 | pAB26 | | PD-01-08 | pAB27 | | PD-01-09 | pFG173 | | PD-01-10 | PBHG10 | | PD-01-11 | PBHG11 | | PD-01-12 | PBHGE3 | | PD-01-13 | pCA3 | | PD-01-14 | pCA4 | | PD-01-15 | pCA13 | | PD-01-16 | pCA14 | | PD-01-17 | pCA17 | | PD-01-18 | pCA18 | | PD-01-19 | PBHG9 | | PD-01-20 | PHCMVsp1LacZ | | PD-01-21 | pMH4 | | PD-01-22 | pMH5 | | PD-01-25 | pDC311 | | PD-01-26 | pDC312 | | PD-01-27 | pDC315 | | PD-01-28 | pDC316 | | PD-01-29 | pDC411 | | PD-01-30 | pDC412 | | PD-01-31 | pDC415 | | PD-01-32 | pDC416 | | PD-01-33 | pDC511 | | PD-01-34 | pDC512 | | PD-01-35 | pDC515 | | PD-01-36 | pDC516 | | PD-01-37 | pBHGfrtΔE1FLP | | PD-01-38 | pBHGfrtΔE1,3FLP | | PD-01-39 | pBHGloxΔE1Cre | | PD-01-40 | pBHGloxΔE1,3Cre | | PD-01-41 | pMH5（I） | | PD-01-42 | AdCre1 | | PD-01-54 | AdCreM2 | | PD-01-44 | AdfloxLacZ1 | | PD-01-45 | Adfloxluc | | PD-01-46 | PDC315（io） | | PD-01-47 | PDC316（io） | | PD-01-48 | PDC515（io） | | PD-01-49 | PDC516（io） | | PD-01-53 | Adeno Helper Virus H14 | | PD-02-01 | 293 Low Passage Cells | | PD-02-02 | 293 N3S Suspension Cells | | PD-02-03 | 293 E4pIX Cells | | PD-02-04 | 293IQ Cells | | PD-02-08 | 293 Cre4 Cells | |
